Contact: Lauren Woods
The Mount Sinai Hospital / Mount Sinai School of Medicine
Caption: Mount Sinai's novel HDL nanoparticle (red), loaded with a statin drug, specifically targets and locally treats inflammatory macrophage cells (green) hiding inside high-risk plaque within blood vessels.
Credit: Mount Sinai
Usage Restrictions: None
Related news release: Novel nanotherapy breakthrough may help reduce recurrent heart attacks and stroke